Novoic

medical devices

About

Novoic is a London-based digital health company that specializes in AI-enabled software for detecting cognitive impairments and neurological diseases, including Alzheimer's disease. Founded in June 2019 by researchers from Oxford and Cambridge, Novoic uses advanced machine learning and natural language processing to analyze vocal and linguistic patterns. This technology allows for the objective profiling and monitoring of neurological conditions, enabling diagnosis long before clinical symptoms typically appear. The company develops innovative voice diagnostics tools that serve as clinical instruments for early detection of neurological diseases. By capturing and interpreting speech data, Novoic provides a non-invasive and accessible method for monitoring neurological health. Their services primarily target healthcare providers, researchers, and pharmaceutical companies involved in the diagnosis, monitoring, and drug development of neurological diseases. Novoic aims to enhance clinical trials and patient care through objective, speech-based biomarkers, supporting early intervention and improved precision in treatment.

Technologies

Route 53 MailJet Gmail Google Apps Microsoft Office 365 Amazon AWS Nginx Mobile Friendly Lever Node.js Render Data Analytics React Native Android IoT Docker Rippling Bullhorn Reviews Vincere

Keywords

digital biotech biotech nlp ai ml speech processing digital diagnostics alzheimers parkinsons huntingtons multiple schlerosis neurodegenerative dementias motor diseases speech disorders rare neurological diseases digital health early detection clinical trials patient recruitment patient screening digital clinical trials valuebased healthcare medical equipment manufacturing hipaa/gdpr compliance biomarker detection multi-site clinical trials high data integrity medical ai software predictive speech biomarkers clinical validation

Location

23 Lilestone Street, London, England, United Kingdom, NW8 8

Related Companies

Companies in the same industry